Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run-Ling Wang

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Bioorganic Chemistry|February 18, 2022
Structure-based discovery of a specific SHP2 inhibitor with enhanced blood-brain barrier penetration from PubChem databaseYing Ma, Wei-Ya Li, Ting Sun, et al.
Drug Design, Development and Therapy|November 26, 2014
Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazoneXue-Jiao Wang, Jun Zhang, Shu-Qing Wang, et al.
Bioorganic & Medicinal Chemistry|September 13, 2012
Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffoldXian-Chao Cheng, Run-Ling Wang, Zhen-Ke Dong, et al.
Computational Biology and Chemistry|April 10, 2021
Design, synthesis, biological evaluation and molecular dynamics of LAR inhibitorsYing-Zhan Sun, Jing-Wei Wu, Shan Du, et al.
Protein and Peptide Letters|May 20, 2011
Docking and molecular dynamics simulations of peroxisome proliferator activated receptors interacting with pan agonist sodelglitazarXu-Yuan Liu, Run-Ling Wang, Wei-Ren Xu, et al.
Oncotarget|April 13, 2017
The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approachesHong-Lian Li, Ying Ma, Ying Ma, et al.
Computational Biology and Chemistry|December 4, 2018
Exploring the reason for increased activity of SHP2 caused by D61Y mutation through molecular dynamicsRui-Rui Wang, Ying Ma, Shan Du, et al.
Computational Biology and Chemistry|February 8, 2018
3D QSAR Pharmacophore Based Virtual Screening for Identification of Potential Inhibitors for CDC25BYing Ma, Hong-Lian Li, Xiu-Bo Chen, et al.
Journal of Biomolecular Structure & Dynamics|September 8, 2016
Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ by core hopping of telmisartanJun Zhang, Xin Liu, Shu-Qing Wang, et al.
Journal of Biomolecular Structure & Dynamics|January 19, 2023
Exploring the mechanism of C473D mutation on CDC25B causing weak binding affinity with CDK2/CyclinA by molecular dynamics studyLi-Peng Li, Hao-Xin Li, Hui Zhou, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Bioorganic Chemistry|February 18, 2022
Structure-based discovery of a specific SHP2 inhibitor with enhanced blood-brain barrier penetration from PubChem databaseYing Ma, Wei-Ya Li, Ting Sun, et al.
Drug Design, Development and Therapy|November 26, 2014
Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazoneXue-Jiao Wang, Jun Zhang, Shu-Qing Wang, et al.
Bioorganic & Medicinal Chemistry|September 13, 2012
Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffoldXian-Chao Cheng, Run-Ling Wang, Zhen-Ke Dong, et al.
Computational Biology and Chemistry|April 10, 2021
Design, synthesis, biological evaluation and molecular dynamics of LAR inhibitorsYing-Zhan Sun, Jing-Wei Wu, Shan Du, et al.
Protein and Peptide Letters|May 20, 2011
Docking and molecular dynamics simulations of peroxisome proliferator activated receptors interacting with pan agonist sodelglitazarXu-Yuan Liu, Run-Ling Wang, Wei-Ren Xu, et al.
Oncotarget|April 13, 2017
The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approachesHong-Lian Li, Ying Ma, Ying Ma, et al.
Computational Biology and Chemistry|December 4, 2018
Exploring the reason for increased activity of SHP2 caused by D61Y mutation through molecular dynamicsRui-Rui Wang, Ying Ma, Shan Du, et al.
Computational Biology and Chemistry|February 8, 2018
3D QSAR Pharmacophore Based Virtual Screening for Identification of Potential Inhibitors for CDC25BYing Ma, Hong-Lian Li, Xiu-Bo Chen, et al.
Journal of Biomolecular Structure & Dynamics|September 8, 2016
Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ by core hopping of telmisartanJun Zhang, Xin Liu, Shu-Qing Wang, et al.
Journal of Biomolecular Structure & Dynamics|January 19, 2023
Exploring the mechanism of C473D mutation on CDC25B causing weak binding affinity with CDK2/CyclinA by molecular dynamics studyLi-Peng Li, Hao-Xin Li, Hui Zhou, et al.
Pageof 6